Gilead Announces Topline Data From Phase 3 STELLAR-3 Study of Selonsertib in Bridging Fibrosis (F3) Due to NASH Read more
Teva Announces Launch of a Generic Version of VESIcare (solifenacin succinate) Tablets in the United States Read more
SK Biopharmaceuticals and twoXAR Sign Collaboration Agreement to Discover and Develop First-In-Class Treatments for Non-Small Cell Lung Cancer Read more
Gilead and insitro Announce Strategic Collaboration to Discover and Develop Novel Therapies for NASH Read more
Lynparza approved in EU for the treatment of germline BRCA-mutated HER2-negative advanced breast cancer Read more
WuXi Biologics and NBE-Therapeutics Announce Comprehensive ADC Development and Manufacturing Partnership Read more